This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Is Ensign Group (ENSG) a Great Growth Stock?
by Zacks Equity Research
If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider Ensign Group (ENSG).
Ensign Group (ENSG) is a Great Momentum Stock: Should You Buy?
by Zacks Equity Research
Does Ensign Group (ENSG) have what it takes to be a top stock pick for momentum investors? Let's find out.
Acadia Healthcare Up 32% YTD: What's Driving the Rally?
by Zacks Equity Research
Acadia Healthcare's strong presence in the growing behavioral healthcare business with solid fundamentals has helped the stock to rally.
Ensign Group (ENSG) on Buyout Spree to Enrich Portfolio
by Zacks Equity Research
Ensign Group (ENSG) purchases the assets of Preceptor Health Care and the real estate and operations of Golden Palms Rehabilitation and Retirement.
Nursing Industry Outlook Bright on Low-Cost Care & Demography
by Sapna Bagaria
An aging baby boomer population, need for low-cost care facilities and consolidation should aid the growth of the nursing industry.
Ensign Group (ENSG) Up 5.1% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Ensign Group (ENSG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Ensign Group (ENSG): Attractive Stock to Own
by Zacks Equity Research
Strong fundamentals along with changing U.S. demography are expected to favor The Ensign Group (ENSG).
Will Ensign Group to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor The Ensign Group.
Why Ensign Group (ENSG) Stock Might be a Great Pick
by Zacks Equity Research
Ensign Group (ENSG) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Are You Looking for a Top Momentum Pick? Why Ensign Group (ENSG) is a Great Choice
by Zacks Equity Research
Does Ensign Group (ENSG) have what it takes to be a top stock pick for momentum investors? Let's find out.
Ensign Group (ENSG) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Ensign Group (ENSG) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Ensign Group (ENSG) Q1 Earnings Beat Estimates, Rise Y/Y
by Zacks Equity Research
Ensign Group's (ENSG) first-quarter earnings increase owing to a robust revenue stream.
Ensign Group (ENSG) Surpasses Q1 Earnings Estimates
by Zacks Equity Research
Ensign Group (ENSG) delivered earnings and revenue surprises of 1.85% and -1.27%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Ensign Group (ENSG) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Ensign Group (ENSG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Ensign Up More Than 90% in a Year: Will the Rally Continue?
by Zacks Equity Research
Strong fundamentals along with industry's growth drivers are ensuring growth at Ensign (ENSG)
Has The Ensign Group (ENSG) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (ENSG) Outperforming Other Medical Stocks This Year?
The Zacks Analyst Blog Highlights: Ensign, Air China and Wal-Mart de Mexico
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Ensign, Air China and Wal-Mart de Mexico
Should First Trust Small Cap Growth AlphaDEX Fund (FYC) Be on Your Investing Radar?
by Sweta Killa
Style Box ETF report for FYC
Ensign Group (ENSG) Down 1.7% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Ensign Group (ENSG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Stuck at 2800: Zacks March Market Strategy
by John Blank
Welcome to March. A relatively uninspiring period for the S&P 500 index has gotten underway. This key large-cap index is now trading in a tight range.
Arm of Ensign Group Unit Buys All County Home Care and Hospice
by Zacks Equity Research
A unit of Ensign Group's (ENSG) subsidiary buys the assets of All County Home Care and Hospice to boost its health and hospice portfolio.
Ensign Group Buys Nursing Hub to Expand in South California
by Zacks Equity Research
Ensign Group (ENSG) purchases Downey Care Center to penetrate into Southern Californian region and enrich its portfolio.
Here's Why You Should Add Ensign Group to Your Portfolio Now
by Zacks Equity Research
Banking on solid growth strategies and increasing revenues, Ensign Group (ENSG) has great potential to offer benefits to investors.
Community Health (CYH) Q4 Loss Wider Than Expected, Down Y/Y
by Zacks Equity Research
Community Health's (CYH) Q4 results disappoint with loss from decline in admissions, partially offset by lower expenses.
The Ensign Group, Inc. (ENSG) Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in The Ensign Group, Inc. (ENSG).